Physical training in patients with heart failure

• Main Authors: Barbara Fletcher, RN, MN, FAAN, Peter Magyari, PHD, Karin Prussak, DNP, ACNP-C, CCRN, James Churilla, PHD, MPH, FACSM
• Format: Article
• Language: English
• Published: Elsevier 2012-11-01
• Series: Revista Médica Clínica Las Condes
• Subjects: CHF; heart failure; physical activity; quality of life; aerobic; muscular strength
• Online Access: http://www.sciencedirect.com/science/article/pii/S0716864012703772

Heart failure is a primary health concern in North and South America, with hospitalizations for heart failure as the primary diagnosis continuing to rise. There is a positive relationship between the prevalence of heart failure and age. However, mortality from heart failure is on the decline due to medical advancements, pharmacotherapy and nonpharmacological interventions. One of these nonpharmacological interventions is physical training or exercise. Physical training or exercise is becoming widely accepted by the medical community as a viable option in the medical management of stable heart failure patients. Both aerobic and resistance type exercise have been shown to be efficacious in stable heart failure patients. Evidence now exists not only supporting exercise to improve or maintain physical function in heart failure patients, but also quality of life. Many studies have shown that utilizing exercise in this population improves mood and overall self-reported well being. While the myocardial benefits from exercise may be minimal in heart failure patients, the peripheral benefits leading to improved physical function and preservation of independence are indispensible. Based on the research that has been conducted in the area of exercise and heart failure to this point, clinicians working with this population have the data necessary to prescribe evidence-based exercise prescriptions that can be utilized as part of a comprehensive medical management approach. Currently, several medical position statements endorse exercise as a safe and effective modality in heart failure patients.